Layla Moran has been writing for the New European on the problems that exiting Euratom, the organisation founded in 1957 to create a specialist market for nuclear power in Europe.
She said:
The government has said it wants a “close association” with the Euratom Research and Training Programme and will seek open trade arrangements for nuclear goods. Both laudable ambitions – but this could all be best resolved by remaining in Euratom instead of creating uncertainty and seeking to negotiate what will certainly be a second rate option. In the meantime, the brilliant nuclear scientists from the EU, working together with their UK colleagues at places like Culham in Oxfordshire, on vital nuclear fusion research, are left in limbo. Some of these people, taking their precious skills with them, have already begun to drift away from the UK.
Then there is the issue of medical radioisotopes. As Mike Galsworthy explained in theNew European last week, these nuclear materials are used in cancer treatments and have very short half-lives, so any delays at borders would diminish the number of doses available. Those in the medical industry are deeply concerned.
What could be more pressing than making sure cancer patients still get treated? Well, it seems that, once again, keeping the fractious Tory party together through insistence on delivering a hard Brexit trumps the national interest.
The Government is keen to play this down, and accuses those who raise it as scaremongers, but the industry needs more than just assurances from the Government that a ‘close relationship’ will be achievable. Industry experts suggest it could take up to seven years to negotiate a treaty as wide-ranging as Euratom so I fail to see how we are going to get this finished in time.
You can read the whole article here.
* Newshound: bringing you the best Lib Dem commentary in print, on air or online.


